Friends! In this video, I'm going to do an analysis on Nike stock, Costco stock and PG stock.
2 extracted signals · 1 resolved · 1 still active
The Patient InvestorIndependent analyst profile- Source published
- 20 Dec 2025, 20:32 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
AI-generated source summary
The analysis focuses on three quality stocks: Nike, Costco, and Procter & Gamble. Nike is currently trading at $58.71, down 57% over five years, largely due to temporary demand from stimulus checks and subsequent inventory issues. Despite recent earnings showing 53 cents EPS versus 38 cents expected, and North American sales up 9%, China revenue dropped 17%. The forward P/E of 30x is considered high for expected low single-digit revenue decline in Q3 and potential 2% gross margin drop due to tariffs. However, projected EPS growth is 50% next year and 23% the year after. The 5-year target EPS for 2030 is estimated at $4.06, leading to a target price of $121.8 with a 30x P/E, or $101.5 with a 25x P/E. A fail bound is inferred at $45, below the suggested safety entry point of $50. Costco, currently at $855.62, is down 13% in six months but still trades at a high forward P/E of 41x and trailing P/E of 49x, which the analyst deems excessive compared to tech giants. The company shows healthy 7% comparable sales growth and expected 11% EPS growth for the next five years. Using an 11% EPS growth and 49x P/E, the 2030 target is $1506.04. A reversion to a 38x P/E would yield $1167.95. The suggested buying range for dollar-cost averaging is between $780 and $600, with a fail bound at $600. Procter & Gamble, at $144.46, is labeled a 'trap' due to market disruption from Amazon's in-house brands and influencers promoting cheaper alternatives. Organic sales grew 2% with 0% organic volume growth, and core EPS growth is only 3%. The stock trades at 20x forward earnings, still considered overvalued. Despite being a dividend king with a 3% yield and a 4.6% FCF yield, annual returns are estimated at 7-8%. Given the 'trap' and overvalued sentiment, a price target of $150 is inferred, with an upward fail bound of $160, signaling a breakout from the expected range-bound performance.
AI-generated summary based on the source content.
Signal outcomes at a glance
Partially ResolvedSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Live evaluation in progress
1 signal remains active.
The Patient Investor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.